Current approaches toward identifying a correlate of immune protection from tuberculosis

Current approaches toward identifying a correlate of immune protection from tuberculosis

<strong>Introduction:</strong> Mycobacterium tuberculosis kills more people than any other pathogen. Vaccination is the most cost-effective control measure for any infectious disease. Development of an effective vaccine against tuberculosis is hindered by the uncertain predictive value o...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Satti, I, McShane, H
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Taylor and Francis 2018

Míreanna comhchosúla

Current approaches toward identifying a correlate of immune protection from tuberculosis
de réir: Iman Satti, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Correlates of immune protection from tuberculosis.
de réir: Fletcher, H
Foilsithe / Cruthaithe: (2007)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
de réir: Stylianou, E, et al.
Foilsithe / Cruthaithe: (2019)

Vaccines for tuberculosis
de réir: McShane, H
Foilsithe / Cruthaithe: (2013)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
de réir: Morrison, H, et al.
Foilsithe / Cruthaithe: (2023)

Human and Bovine Tuberculosis
de réir: McShane, H
Foilsithe / Cruthaithe: (2016)

Vaccine strategies against tuberculosis
de réir: H McShane
Foilsithe / Cruthaithe: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
de réir: McShane, H
Foilsithe / Cruthaithe: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
de réir: McShane, H
Foilsithe / Cruthaithe: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
de réir: McShane, H
Foilsithe / Cruthaithe: (2011)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
de réir: Pinpathomrat, N, et al.
Foilsithe / Cruthaithe: (2021)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
de réir: Hazel Morrison, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
de réir: McShane, H
Foilsithe / Cruthaithe: (2020)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
de réir: McShane, H
Foilsithe / Cruthaithe: (2023)

Tuberculosis vaccines: Progress and challenges
de réir: Checkley, A, et al.
Foilsithe / Cruthaithe: (2011)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
de réir: O'Shea, M, et al.
Foilsithe / Cruthaithe: (2018)

Local pulmonary immunological biomarkers in tuberculosis
de réir: Morrison, H, et al.
Foilsithe / Cruthaithe: (2021)

Why don’t we have an effective tuberculosis vaccine yet?
de réir: Davenne, T, et al.
Foilsithe / Cruthaithe: (2016)

Challenges in developing a controlled human tuberculosis challenge model
de réir: Jackson, S, et al.
Foilsithe / Cruthaithe: (2022)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
de réir: Satti, I, et al.
Foilsithe / Cruthaithe: (2022)

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate
de réir: Korompis, M, et al.
Foilsithe / Cruthaithe: (2025)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
de réir: Griffiths, K, et al.
Foilsithe / Cruthaithe: (2013)

Tuberculosis vaccines: current status and future prospects.
de réir: Fletcher, H, et al.
Foilsithe / Cruthaithe: (2006)

Tuberculosis vaccine promises sterilizing immunity.
de réir: Mcshane, H, et al.
Foilsithe / Cruthaithe: (2011)

Local Pulmonary Immunological Biomarkers in Tuberculosis
de réir: Hazel Morrison, et al.
Foilsithe / Cruthaithe: (2021-03-01)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
de réir: Vermaak, S, et al.
Foilsithe / Cruthaithe: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
de réir: Tanner, R, et al.
Foilsithe / Cruthaithe: (2016)

Correlates of protection from tuberculosis
de réir: Peralta Alvarez, MP, et al.
Foilsithe / Cruthaithe: (2023)

Clinical testing of tuberculosis vaccine candidates
de réir: Hatherill, M, et al.
Foilsithe / Cruthaithe: (2016)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
de réir: Dockrell, HM, et al.
Foilsithe / Cruthaithe: (2022)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
de réir: Dean, G, et al.
Foilsithe / Cruthaithe: (2014)

Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV
de réir: Naglaa H. Shoukry
Foilsithe / Cruthaithe: (2021-09-01)

Towards new TB vaccines
de réir: Brazier, B, et al.
Foilsithe / Cruthaithe: (2020)

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate
de réir: Marcellus Korompis, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Antibodies and tuberculosis
de réir: Jacobs, A, et al.
Foilsithe / Cruthaithe: (2016)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
de réir: Mcshane, H, et al.
Foilsithe / Cruthaithe: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
de réir: Matthew K. O’Shea, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Immune correlates of protection as a game changer in tuberculosis vaccine development
de réir: Jing Wang, et al.
Foilsithe / Cruthaithe: (2024-10-01)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guérin
de réir: Minassian, A, et al.
Foilsithe / Cruthaithe: (2012)

A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
de réir: Minassian, A, et al.
Foilsithe / Cruthaithe: (2012)